UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
1943-01-01
Employees
8.1K
Market Cap
-
Website
http://www.utsouthwestern.edu
Clinical Trials
Related News

Non-Interventional F-Two Isoprostane Trial (NIFTI)

Completed
Conditions
Traumatic Brain Injury
First Posted Date
2007-07-25
Last Posted Date
2020-03-16
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
50
Registration Number
NCT00505908
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Parkland Memorial Hospital, Dallas, Texas, United States

Lipid, Glycemic, and Insulin Responses to Meals Rich in Different Fatty Acids

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
First Posted Date
2007-05-28
Last Posted Date
2007-05-28
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
11
Registration Number
NCT00479791
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

Pharmacokinetic Response to BPI in Burns

Phase 2
Terminated
Conditions
Burns
Interventions
Drug: BPI
First Posted Date
2007-04-19
Last Posted Date
2019-11-20
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
4
Registration Number
NCT00462904
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UT Southwestern Medical Center, Dallas, Texas, United States

Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both

Not Applicable
Completed
Conditions
Cholesterol, LDL
First Posted Date
2007-04-18
Last Posted Date
2007-04-18
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
240
Registration Number
NCT00461968
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

Therapeutic Approaches to HAART-Induced Lipodystrophy

Phase 2
Completed
Conditions
HIV Infections
Lipodystrophy
Interventions
Drug: Leptin
Other: Placebo
First Posted Date
2007-04-18
Last Posted Date
2019-05-09
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
23
Registration Number
NCT00461552
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UT Southwestern Medical Center, Dallas, Texas, United States

Novel Therapies for Metabolic Complications of Lipodystrophies

First Posted Date
2007-04-09
Last Posted Date
2018-10-16
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
4
Registration Number
NCT00457938
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UT Southwestern Medical Center, Dallas, Texas, United States

Cholic Acid for Hepatic Steatosis in Lipodystrophy

Phase 2
Completed
Conditions
Hepatic Steatosis
Interventions
Drug: Cholic Acid
First Posted Date
2007-04-06
Last Posted Date
2019-01-17
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
18
Registration Number
NCT00457639
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Mechanisms of Lipodystrophy in HIV-Infected Pateints

Phase 4
Completed
Conditions
HIV Infections
Interventions
Drug: Efavirenz
Drug: Nelfinavir
First Posted Date
2007-04-06
Last Posted Date
2019-07-18
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
56
Registration Number
NCT00457665
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Quetiapine for Bipolar Disorder and Alcohol Dependence

First Posted Date
2007-04-06
Last Posted Date
2016-04-05
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
90
Registration Number
NCT00457197
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Psychoneuroendocrine Research Program, Dallas, Texas, United States

rTMS for Treatment of Depressed Phase of Bipolar Disorder Type II

First Posted Date
2007-03-14
Last Posted Date
2016-06-09
Lead Sponsor
University of Texas Southwestern Medical Center
Registration Number
NCT00447096
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy